| |
Oral cancer is the disease that produces the highest mortality of all disorders within the scope of responsibilities of dentists. With this in mind, research and training efforts within the School of Dental Medicine related to oral cancer have been greatly expanded. This effort is aimed at applying the newest biological findings to the prevention, detection, and treatment of oral cancer. The school enjoys collaborative arrangements with a number of cancer research and treatment facilities, including Roswell Park Cancer Institute; the University at Buffalo Departments of Otolaryngology, Medical Oncology, and Pathology of the School of Medicine and Biological Sciences; The Buffalo General Hospital; the Department of Neoplastic Disease of Mt. Sinai Hospital in New York City; the Peptide Hormone Research Center at Tulane University; the Rochester General Hospital Laser Center, and Eastman Dental Center.
Active preclinical and clinical studies include studies of anti-oncogenes, endocrine control of cancer and cancer progression, photodynamic therapy and laser surgery. Students have been involved at all levels of the these studies - learning research of the these studies - learning research design, doing laboratory projects, evaluating patients with lesions, and in the surgical and medical treatment of patients. Students have published numerous papers in this field, presented their findings at a wide range of dental, medical and biological meetings, and received many national awards.
[Faculty] [Students] [Links] [UB Info] [Community Outreach] [SDM Home Page] School of Dental Medicine, University at Buffalo, State University of New York |